Myovant Sciences Ltd. Langfristige Verbindlichkeiten 2011-2026 | MYOV

Langfristige Verbindlichkeiten Jährlich Myovant Sciences Ltd.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	128 M	96.7 M	44.3 M	165 K	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
128 M	165 K	67.4 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
Scholar Rock Holding Corporation SRRK	85 M	$ 43.62	-1.33 %	$ 5 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Stoke Therapeutics STOK	8.1 M	$ 33.98	0.83 %	$ 2.01 B	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.23	-5.04 %	$ 314 M	Britain
EyePoint Pharmaceuticals EYPT	58.3 M	$ 13.09	0.23 %	$ 959 K	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
China SXT Pharmaceuticals SXTC	212 K	$ 1.38	4.55 %	$ 1.96 M	China
Takeda Pharmaceutical Company Limited TAK	5.96 T	$ 18.16	0.55 %	$ 28.4 B	Japan
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	299 K	$ 1.07	-2.29 %	$ 21.9 M	Israel
Enochian Biosciences ENOB	425 K	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Equillium EQ	8.33 M	$ 2.06	-	$ 118 M	USA
Theravance Biopharma TBPH	521 M	$ 14.97	-1.45 %	$ 753 M	Cayman-islands
Eton Pharmaceuticals ETON	4.56 M	$ 23.43	-0.09 %	$ 630 M	USA
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	70.2 M	$ 47.18	-0.79 %	$ 4.24 B	Schweiz
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.46	0.22 %	$ 855 M	Canada
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA